Navigation Links
Tissue engineering methods earn funding to heal little hearts
Date:2/18/2011

HOUSTON (Feb. 18, 2011) -Texas Children's Hospital in Houston announces that a researcher in its Pediatric Cardiac Bioengineering Laboratory has earned a National Science Foundation Early Career Development (CAREER) Award for his work in studying the causes of congenital heart disease, heart defects, and the development of tissue engineering therapies using stem cells derived from human amniotic fluid. The award comes with new funding of $450,000 to be spread over a five-year period.

Jeffrey Jacot, Ph.D, director of the Pediatric Cardiac Bioengineering Laboratory at the Congenital Heart Surgery Service at Texas Children's Hospital and an assistant professor of bioengineering at Rice University, submitted work based on two years of previously published studies on the effects of substrate stiffness on maturing heart cells, the mechanical environment of cardiovascular tissues, and the development of heart tissue grown from stem cells taken from the amniotic fluid of patients' mothers. His work with cardiac tissue stems from a 2009 grant from the Virginia and L.E. Simmons Family Foundation Collaborative Research Fund, which promotes research among Texas Medical Center scientists, engineers and doctors who might not otherwise work together.

"I am pleased to be part of the groundbreaking congenital heart research at Texas Children's Hospital," said Dr. Jacot. "We hope this work will lead to the development of living heart tissue that might work to 'patch' or reconstruct hearts with congenital defects."

As a principal investigator on several projects, Jacot works alongside surgeons and radiologists at Texas Children's Hospital and with cardiovascular research laboratories at Baylor College of Medicine (BCM) to establish a therapeutically feasible stem cell source and understand how to control growth of new cardiac tissue.

"Dr. Jacot is a talented and highly inventive young member of the biomedical engineering community whose detailed analysis and rationally designed experiments bring a unique approach to the study and treatment of congenital heart disease," said Charles D. Fraser Jr., M.D., surgeon-in-chief and chief of congenital heart surgery at Texas Children's Hospital and professor of surgery at BCM. "Because the regenerative cardiac therapies developed in his lab are grown from amniotic fluid-derived stem cells, they are genetically identical to the child and have potential to grow with the patient with minimal immune response."

Jacot's CAREER Award also includes an interactive exhibition and outreach program for elementary, middle and high school students to be developed in cooperation with the John P. McGovern Museum of Health and Medical Science (MMHM) in Houston. The educational component, which is intended to inspire and help guide the next generation of scientists and engineers, includes field trips and teacher workshops, as well as lectures and problem-based curriculum in systems physiology at Rice.


'/>"/>

Contact: Carol Wittman
cmwittma@texaschildrens.org
832-824-2040
Texas Children's Hospital
Source:Eurekalert

Related medicine news :

1. New study suggests stem cells sabotage their own DNA to produce new tissues
2. Scientists Discover Molecular Pathway for Organ Tissue Regeneration and Repair
3. Step Up to Speak Up Events Use Spoken Word and African-American Greek Tradition of Stepping to Raise Awareness for Organ and Tissue Donation
4. CSMG Technologies, Inc. Engages New Team to Manage Live Tissue Connect, Inc.
5. Paired drugs kill precancerous colon polyps, spare normal tissue
6. Tissue engineers create a new way to assemble artificial tissues
7. Ultrasound could boost tissue implant success
8. Color-coded tracking method helps scientists analyze outcomes of newly transplanted tissue
9. Molecular Signatures in Post-Mortem Brain Tissue of Younger Individuals at High Risk for Alzheimer's Disease
10. Scholar calls for a new legal, ethical framework for research with human tissue specimens
11. New method of tissue banking makes gene analysis more practical for lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... Grocery Company to the list of fine retailers selling biodegradable, hanging flushable wipes ... H.E.B., a large supermarket chain headquartered in San Antonio, Texas, operates more than ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission for Health Care ... of America (HCAOA). This agreement allows HCAOA members to receive special pricing on ... on Accreditation University (AU) educational resources that help prepare HCAOA members for ACHC ...
(Date:4/28/2017)... ... April 28, 2017 , ... Getting enough sleep affects much more than energy – ... just 19 hours without sleep can compromise motor reaction time, which can increase the risk ... Insurance is sharing the following tips from the NSF to help you sleep better and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back ... joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified ... The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike ...
(Date:4/28/2017)... MA (PRWEB) , ... April 28, 2017 , ... People ... for older people. “Wearing a hearing aid doesn’t have the stigma it had when ... & Hearing Associates of Greater Boston, in a NALA North American Speaker Series ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
Breaking Medicine Technology: